News & Analysis as of September 25, 2024

Regulatory Oversight

+ Follow

Understanding Pharmacy Benefit Managers: The PBM Landscape Explained
The DEA Is Knocking at Your Door . . . Are You Prepared? – Diagnosing Health Care
340B Drug Pricing Program Compliance
Podcast: Post-Dobbs Access to Reproductive Health Care and Abortion-Inducing Drugs - Diagnosing Health Care
Podcast: Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act - Diagnosing Health Care
Hooper, Kearney and Macklin on Cutting Edge Topics in the False Claims Act
Edible Bites Episode 3: Cannabis and Life Sciences Video Webinar Series
Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video Series
Drug Pricing Initiatives During the Trump Presidency
Bill on Bankruptcy: AMR Make-Whole Opinion Vulnerable on Appeal

Compliance Risk Alert: Opioid Warning Letters issued by the U.S. Department of Justice Target Prescribers

Sheppard Mullin Richter & Hampton LLP on 2/7/2019

U.S. Attorney’s Offices (“USAOs”) across the country are issuing warning letters to physicians and other prescribers (collectively, “Prescribers”) cautioning them about their opioid prescribing practices (the “Warning...more

'Opioids and Legal Enforcement — A Primer' - HarrisMartin's Drugs & Medical Devices

Bradley Arant Boult Cummings LLP on 7/19/2018

The opioid crisis in America is now well known, affecting a staggering number of people directly or indirectly and occupying a regular place in media reports and political discussions. In addition to potential public health...more

2 Results

View per page

Page: of 1

Pharmacies › Physicians › Regulatory Oversight

Compliance Risk Alert: Opioid Warning Letters issued by the U.S. Department of Justice Target Prescribers

'Opioids and Legal Enforcement — A Primer' - HarrisMartin's Drugs & Medical Devices

"My best business intelligence, in one easy email…"